{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:52:23Z","timestamp":1789199543975,"version":"build-2803163510"},"reference-count":48,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.3960\/jslrt.22034","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T22:10:49Z","timestamp":1675030249000},"page":"1-11","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic indices for peripheral T-cell lymphoma - not otherwise specified and adult T-cell leukemia\/lymphoma: From past to future"],"prefix":"10.3960","volume":"63","author":[{"given":"Kenji","family":"Ishitsuka","sequence":"first","affiliation":[{"name":"Department of Hematology and Rheumatology, Kagoshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Melnyk A, Rodriguez A, Pugh WC, Cabannillas F. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma. Blood. 1997; 89: 4514-4520.","DOI":"10.1182\/blood.V89.12.4514"},{"key":"2","unstructured":"2 Gisselbrecht C, Gaulard P, Lepage E et al.<\/i> Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA). Blood. 1998; 92: 76-82."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977; 50: 481-492.","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Poiesz BJ, Ruscetti FW, Gazdar AF et al.<\/i> Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980; 77: 7415-7419.","DOI":"10.1073\/pnas.77.12.7415"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014; 15: e517-e526.","DOI":"10.1016\/S1470-2045(14)70202-5"},{"key":"6","unstructured":"6 Hino S, Katamine S, Miyata H et al.<\/i> Primary prevention of HTLV-1 in Japan. Leukemia. 1997; 11(suppl 3): 57-59."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Yamaguchi K, Watanabe T. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol. 2002; 76(suppl 2): 240-245.","DOI":"10.1007\/BF03165123"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005; 24: 6058-6068.","DOI":"10.1038\/sj.onc.1208968"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 . A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993; 329: 987-994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Fukushima T, Nomura S, Shimoyama M et al.<\/i> Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol. 2014; 166: 739-748.","DOI":"10.1111\/bjh.12962"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Gallamini A, Stelitano C, Calvi R et al.<\/i> Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004; 103: 2474-2479.","DOI":"10.1182\/blood-2003-09-3080"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Went P, Agostinelli C, Gallamini A et al.<\/i> Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006; 24: 2472-2479.","DOI":"10.1200\/JCO.2005.03.6327"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Vose J, Armitage J, Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008; 26: 4124-4130.","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Vose JM; The International PTCL Project. International Peripheral T-Cell Lymphoma (PTCL) Clinical and Pathologic Review Project: Poor outcome by prognostic indices and lack of efficacy with anthracyclines. ASH Annual Meeting Abstracts. 2005; 106: 811.","DOI":"10.1182\/blood.V106.11.811.811"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Guti\u00e9rrez-Garc\u00eda G, Garc\u00eda-Herrera A, Cardesa T et al.<\/i> Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol. 2011; 22: 397-404.","DOI":"10.1093\/annonc\/mdq359"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Lin HN, Liu CY, Pai JT et al.<\/i> How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models? Blood Cancer J. 2012; 2: e93.","DOI":"10.1038\/bcj.2012.23"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Weisenburger DD, Savage KJ, Harris NL et al.<\/i> Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011; 117: 3402-3408.","DOI":"10.1182\/blood-2010-09-310342"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Wang T, Feldman AL, Wada DA et al.<\/i> GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood. 2014; 123: 3007-3015.","DOI":"10.1182\/blood-2013-12-544809"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Iqbal J, Wright G, Wang C et al.<\/i> Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 2014; 123: 2915-2923.","DOI":"10.1182\/blood-2013-11-536359"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Amador C, Greiner TC, Heavican TB et al.<\/i> Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry. Blood. 2019; 134: 2159-2170.","DOI":"10.1182\/blood.2019000779"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Vasmatzis G, Johnson SH, Knudson RA et al.<\/i> Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood. 2012; 120: 2280-2289.","DOI":"10.1182\/blood-2012-03-419937"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Heavican TB, Bouska A, Yu J et al.<\/i> Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. 2019; 133: 1664-1676.","DOI":"10.1182\/blood-2018-09-872549"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Watatani Y, Sato Y, Miyoshi H et al.<\/i> Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia. 2019; 33: 2867-2883.","DOI":"10.1038\/s41375-019-0473-1"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79: 428-437.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 . Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987). Leuk Res. 1991; 15: 81-90.","DOI":"10.1016\/0145-2126(91)90087-A"},{"key":"26","unstructured":"26 Shimoyama M. Chemotherapy of ATL. In : Takatsuki K (ed) : Adult T-Cell Leukemia. Oxford, Oxford University Press. 1994; pp. 221-237."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Tsukasaki K, Hermine O, Bazarbachi A et al.<\/i> Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009; 27: 453-459.","DOI":"10.1200\/JCO.2008.18.2428"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Phillips AA, Shapira I, Willim RD et al.<\/i> A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma: a multicenter clinicopathologic experience and new prognostic score. Cancer. 2010; 116: 3438-3446.","DOI":"10.1002\/cncr.25147"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Beltran B, Qui\u00f1ones P, Morales D, Cotrina E, Castillo JJ. Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia\/lymphoma. Leuk Res. 2011; 35: 334-339.","DOI":"10.1016\/j.leukres.2010.08.006"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Katsuya H, Ishitsuka K, Utsunomiya A et al.<\/i> Treatment and survival among 1594 patients with ATL. Blood. 2015; 126: 2570-2577.","DOI":"10.1182\/blood-2015-03-632489"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Katsuya H, Yamanaka T, Ishitsuka K et al.<\/i> Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma. J Clin Oncol. 2012; 30: 1635-1640.","DOI":"10.1200\/JCO.2011.38.2101"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Suzumiya J, Ohshima K, Tamura K et al.<\/i> The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia\/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project. Ann Oncol. 2009; 20: 715-721.","DOI":"10.1093\/annonc\/mdn696"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Tsukasaki K, Utsunomiya A, Fukuda H et al.<\/i> VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007; 25: 5458-5464.","DOI":"10.1200\/JCO.2007.11.9958"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Toyoda K, Tsukasaki K, Machida R et al.<\/i> Possibility of a risk-adapted treatment strategy for untreated aggressive adult T-cell leukaemia-lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG 9801. Br J Haematol. 2019; 186: 440-447.","DOI":"10.1111\/bjh.15950"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Katsuya H, Shimokawa M, Ishitsuka K et al.<\/i> Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma. Blood. 2017; 130: 39-47.","DOI":"10.1182\/blood-2017-01-757542"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Tsukasaki K, Tobinai K, Shimoyama M et al.<\/i> Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109). Int J Hematol. 2003; 77: 164-170.","DOI":"10.1007\/BF02983215"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Yamada Y, Tomonaga M, Fukuda H et al.<\/i> A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol. 2001; 113: 375-382.","DOI":"10.1046\/j.1365-2141.2001.02737.x"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Tamaki K, Morishima S, Nomura S et al.<\/i> Evaluation of two prognostic indices for adult T-cell leukemia\/lymphoma in the subtropical endemic area, Okinawa, Japan. Cancer Sci. 2018; 109: 2286-2293.","DOI":"10.1111\/cas.13641"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Fuji S, Yamaguchi T, Inoue Y et al.<\/i> Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation. Haematologica. 2017; 102: 1258-1265.","DOI":"10.3324\/haematol.2017.164996"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Kataoka K, Iwanaga M, Yasunaga J et al.<\/i> Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma. Blood. 2018; 131: 215-225.","DOI":"10.1182\/blood-2017-01-761874"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Shah UA, Chung EY, Giricz O et al.<\/i> North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood. 2018; 132: 1507-1518.","DOI":"10.1182\/blood-2018-01-824607"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Sakamoto Y, Ishida T, Masaki A et al.<\/i> Clinical significance of TP53 mutations in adult T-cell leukemia\/lymphoma. Br J Haematol. 2021; 195: 571-584.","DOI":"10.1111\/bjh.17749"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Bazarbachi A, Suarez F, Fields P, Hermine O. How I treat adult T-cell leukemia\/lymphoma. Blood. 2011; 118: 1736-1745.","DOI":"10.1182\/blood-2011-03-345702"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Cuadros M, Dave SS, Jaffe ES et al.<\/i> Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol. 2007; 25: 3321-3329.","DOI":"10.1200\/JCO.2006.09.4474"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Piccaluga PP, Fuligni F, De Leo A et al.<\/i> Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study. J Clin Oncol. 2013; 31: 3019-3025.","DOI":"10.1200\/JCO.2012.42.5611"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Nakagawa M, Nakagawa-Oshiro A, Karnan S et al.<\/i> Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia\/lymphoma. Clin Cancer Res. 2009; 15: 30-38.","DOI":"10.1158\/1078-0432.CCR-08-1808"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Valleron W, Ysebaert L, Berquet L et al.<\/i> Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood. 2012; 120: 3997-4005.","DOI":"10.1182\/blood-2012-06-438135"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Xia H, Yamada S, Aoyama M et al.<\/i> Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia\/lymphoma. Hum Pathol. 2014; 45: 1192-1198.","DOI":"10.1016\/j.humpath.2014.01.017"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/1\/63_22034\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T05:24:25Z","timestamp":1680326665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/1\/63_22034\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.22034","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"22034"}}